FDA
-
-
-
-
-
-
-
FibroGen Reports Third Quarter 2023 Financial Results
-
-
-
-
-
-
-
FibroGen Reports First Quarter 2023 Financial Results
-
-
-
-
-
-
-
FibroGen Reports Third Quarter 2021 Financial Results
-
-
-
-
-
-
-
Pre-Open Stock Movers 07/16: (GLG) (AEHR) (MGI) Higher; (FGEN) (AOUT) (CRVS) Lower (more...)
-
-
-
-
-
-
-
Astellas and FibroGen (FGEN) Announce Positive CHMP Opinion for EVRENZO for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease
-
-
-
-
-
-
-
FibroGen Reports First Quarter 2021 Financial Results
-
-
-
-
-
-
-
FGEN SHAREHOLDER FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fibrogen Inc.
-
251,368 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All